21,744 Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC) Purchased by Bank OZK

Bank OZK bought a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 21,744 shares of the company’s stock, valued at approximately $1,700,000.

A number of other institutional investors have also recently bought and sold shares of GEHC. LGT Financial Advisors LLC increased its stake in GE HealthCare Technologies by 1,673.3% in the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after purchasing an additional 251 shares in the last quarter. Capital Performance Advisors LLP purchased a new position in GE HealthCare Technologies during the 3rd quarter valued at about $26,000. Ashton Thomas Securities LLC purchased a new position in GE HealthCare Technologies during the 3rd quarter valued at about $26,000. Darwin Wealth Management LLC purchased a new position in GE HealthCare Technologies during the 3rd quarter valued at about $31,000. Finally, Continuum Advisory LLC lifted its holdings in shares of GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after buying an additional 168 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ:GEHC opened at $87.35 on Friday. The business’s fifty day moving average price is $86.17 and its two-hundred day moving average price is $86.10. GE HealthCare Technologies Inc. has a fifty-two week low of $74.51 and a fifty-two week high of $94.80. The stock has a market capitalization of $39.94 billion, a price-to-earnings ratio of 20.17, a price-to-earnings-growth ratio of 3.19 and a beta of 1.15. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. The company had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. As a group, analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms recently weighed in on GEHC. Citigroup boosted their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. Wells Fargo & Company lifted their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. Finally, Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price objective for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $97.67.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.